B cell immunodeficiency

50
B cell immunodeficiency Sara Mohammad Abuel Gassim November 2009

description

B cell immunodeficiency Sara Mohammad Abuel Gassim November 2009. - PowerPoint PPT Presentation

Transcript of B cell immunodeficiency

Page 1: B cell immunodeficiency

B cell immunodeficiency

Sara Mohammad Abuel Gassim November 2009

Page 2: B cell immunodeficiency

Introduction

• B lymphocytes, named after their site of origin in the bursa of Fabricius in birds or in

the bone marrow in humans, form the basis for humoral immunity by their

production of immunoglobulins.

• B-cell disorders are divided into defects of B-cell development/ immunoglobulin

production (immunodeficiencies) and excessive/uncontrolled proliferation

(lymphomas, leukemias).

Page 3: B cell immunodeficiency

Immuodeficiency• Immunodeficiency is the failure of the immune system to protect against disease or

malignancy.

• Primary Immunodeficiency is caused by genetic or developmental defects in the

immune system. These defects are present at birth but may show up later on in life.

• Secondary or acquired immunodeficiency is the loss of immune function as a result

of exposure to disease agents, environmental factors, immunosuppression, or aging.

• Bacterial, viral, protozoan, helminthic and fungal infections may lead to B cell, T

cell, PMN and macrophage deficiencies.

• Most prominent among these is acquired immunodeficiency syndrome (AIDS).

• Secondary immunodeficiencies are also seen in malignancies.

Page 4: B cell immunodeficiency

Pathophysiology• During fetal development, hematopoiesis including lymphopoiesis, is multicentric.

• After birth, the bone marrow becomes the exclusive production site for lymphoid

progenitors.

• B and T cells, type 2 dendritic cells, and natural killer (NK) cells share a common

ancestor, ie, common lymphoid progenitor (CLP).

• CLP differentiates into 2 intermediate progenitors: early B cells and

T/NK/dendritic trilineage cells. Both continue their development in the bone

marrow through an antigen-independent process called primary lymphopoiesis

(PL).

• Recognized stages of PL are pro-B cell, pre-B cell, immature B cell, and mature B

cell.

Page 5: B cell immunodeficiency

B cell development

Page 6: B cell immunodeficiency

• Secondary B lymphopoiesis is an antigen-dependent process and occurs in the

germinal center of peripheral lymphoid organs with specific antibody production.

• Secondary T lymphopoiesis is also an antigen-dependent process and occurs in the

thymus.

• Secondary lymphopoiesis (SL) begins when mature B cells enter the extrafollicular

area of lymphoid tissue and differentiate into short-lived plasma cells and memory

cells after first being stimulated by antigen-presenting cells.

Page 7: B cell immunodeficiency
Page 8: B cell immunodeficiency

• Memory cells travel to the primary follicle, where, after exposure to dendritic

cells, they differentiate into centroblasts (immunoglobulin class-switch).

• Centroblasts progress to centrocytes with high-affinity antibody production, and

then they differentiate further to long-term memory cells and plasmablasts. The

latter migrate back to the bone marrow and start producing immunoglobulins.

Page 9: B cell immunodeficiency
Page 10: B cell immunodeficiency
Page 11: B cell immunodeficiency

• The earlier the defect, the more devastating the effect on lymphopoiesis.

• Defects occurring at the CLP stage or those affecting processes common to B-

and T-cell development result in combined immunodeficiency involving B, T,

and NK cells.

Page 12: B cell immunodeficiency

Primary immunodeficiency

Page 13: B cell immunodeficiency

• Primary B-cell disorders result in a complete or partial absence of one or more

immunoglobulin isotypes.

• Regardless of the primary cause, the symptoms depend on the type and severity of

the immunoglobulin deficiency and the association of cell-mediated

immunodeficiency.

• In general, severe immunoglobulin deficiency results in recurrent infections with

specific microorganisms in certain anatomical sites.

Page 14: B cell immunodeficiency

IgG deficiency

• IgG deficiencies may be divided into 2 categories. The first is selective IgG

deficiency, which consists of an isolated deficiency of IgG with normal levels

of IgA, IgM, IgD, and IgE. The second is a deficiency of IgG accompanied by

inadequate levels of other immunoglobulin isotypes.

• This may occur in various conditions, including X-linked

agammaglobulinemia (X-LA), common variable immunodeficiency (CVID),

and hyper-IgM syndromes.

Page 15: B cell immunodeficiency
Page 16: B cell immunodeficiency

X-linked agammaglobulinemia(XLA)

• Also known as Bruton agammaglobulinemia, is the result of a mutation of the

BTK gene. Pro-B cells are present in normal number, but they are unable to

mature to pre-B cells.

• The BTK gene is present on Xq21.3-q22, and its defect results in deficiency of

Bruton tyrosine kinase.

• Non-XLA is the result of mu heavy-chain gene deficiency that leads to abortive

production of IgM and failure of B-cell development.

Page 17: B cell immunodeficiency

• Activated tyrosine kinases generate a second wave of messengers by activating

serine/threonine kinases or phosphatases pathways.

• Three major pathways have been identified: the inositol phospholipid

hydrolysis pathway, the phosphatidyl inositol-3-kinase pathway, and the Ras

pathway.

• These pathways converge toward the activation of transcription factors,

resulting in B-cell activation and proliferation.

Page 18: B cell immunodeficiency

Bruton’s Tyrosine Kinase• Signalling molecule B-cell development into anti-body producing plasma cells.• 5 domains all of which can be affected by disease causing alterations.

Page 19: B cell immunodeficiency
Page 20: B cell immunodeficiency
Page 21: B cell immunodeficiency

XLA – summary

• Btk gene mutation.

• Loss of functional tyrosine kinase.

• Blocked B cell maturation.

Page 22: B cell immunodeficiency

Common Variable Immunodeficiency(CVID)

• Mature B cells are normal in number and morphology but fail to differentiate to

plasma cells because of defective interaction between T and B cells, mostly

caused by a T-cell defect. This defect is thought to be related to a decreased

number and/or function of CD4+ T lymphocytes or, occasionally, to an increased

number of CD8+ T lymphocytes.

• Abnormal responses of B cells to many usual stimuli have also been identified in

vitro.

Page 23: B cell immunodeficiency

• The underlying abnormality in selective IgM deficiency is a defect of helper T-

cell and excessive suppressor T-cell activity.

• The disorder is characterized by a low level of IgM. IgG levels are normal, but

the IgG response is usually decreased.

• Helper T-lymphocyte deficiency has been incriminated in the pathogenesis of

transient hypogammaglobulinemia of infancy (THI) and immunodeficiency with

thymoma.

• The primary defect in selective IgA deficiency is related to a failure of B cells to

differentiate to mature isotype-switched surface IgA-positive B cells and IgA-

secreting plasma cells with appropriate stimuli. The basis for the defect is not

known.

Page 24: B cell immunodeficiency

• B cells in IgA deficiency activated via CD40 and interleukin-10 are capable of

synthesizing and secreting IgA. Defective helper T-cell and excessive suppressor T-

cell activities are occasionally present.

• Cytokine abnormalities have also been described.

• IgG2 is the most common of IgG subclass deficiencies. It occurs either alone or with

IgG4 or IgA deficiency. Its hallmark is an inability to generate antibodies to

polysaccharides.

Page 25: B cell immunodeficiency

Hyper-IgM immunodeficiency

• Individuals with this type of immunodeficiency have low IgA and IgG concentrations

with abnormally high levels of IgM.

• These patients cannot make a switch from IgM to other classes which is attributed to

a defect in CD40L on their CD4 cells. They are very susceptible to pyogenic

infection and should be treated with intravenous gamma-globulins.

Page 26: B cell immunodeficiency

Thymoma

• Some patients with thymomas have an associated IgG deficiency. In most cases, the

thymoma is composed of a benign type of spindle cell, and both B- and T-cell

deficiency have been reported.

• Panhypogammaglobulinemia and deficient cell-mediated immunity usually occur.

• This condition is usually referred to as Good syndrome.

• Removal of the thymoma does not reverse the immunoglobulin deficiency, and

patients may benefit from IgG replacement therapy to prevent recurrent infection.

Page 27: B cell immunodeficiency

Transient hypogammaglobulinemia

• Children, at birth, have IgG levels comparable to that of the mother.

• Because the half life of IgG is about 30 days, its level gradually declines, but by

three months of age normal infants begin to synthesize their own IgG.

• In some infants, IgG synthesis may not begin until they are 2 to 3 years old. This

delay has been attributed to poor T cell help.

• This results in a transient deficiency of IgG which can be treated with gamma-

globulin.

Page 28: B cell immunodeficiency

IgA deficieny

• This is the most common antibody deficiency and results in chronic infections at

mucosal surfaces since IgA is the secretory antibody which protects these surfaces. 

• Since IgG and IgM can compensate, to a significant degree, for the lack of IgA, this

deficiency often goes unnoticed since it usually does not cause serious problems.

• A few patients with IgA deficiency may also develop additional antibody deficiencies

(for example deficiencies in IgG) and/or autoimmune disease with time.

Page 29: B cell immunodeficiency

X-linked immunodeficiency with hyper-IgM(XHM)

• Is related to a deficiency in gp39 (CD40 ligand).

• B cells can initiate the immune response by producing IgM, but they are not

capable of operating the class-switching, hence the overproduction of IgM and

the decrease or absence of the other immunoglobulin isotypes.

• Liver disease, sclerosing cholangitis, and liver/GI malignancies are common in

these patients.

Page 30: B cell immunodeficiency

• The expression of CD40L on the surface of biliary epithelial cells has suggested a

role for CD40-CD40L interaction in the pathogenesis of these complications

through defective control of intracellular pathogens such as Cryptosporidium

parvum, which has been recognized as an important pathogen in these patients.

Page 31: B cell immunodeficiency

Secondary immunodeficiency

Page 32: B cell immunodeficiency

• Also known as acquired immunodeficiency.

• one is born with normal immune responses but some secondary factor or

occurrence causes a decrease in immune responses.

• Secondary immunodeficiency is induced by factors such as:

Page 33: B cell immunodeficiency

Malnutrition• Most common cause of secondary immune deficiency

• Protein-Calorie malnutrition can lead to abnormalities of T cells, B cells and

phagocytes.

• Atrophic and fibrotic thymus.

• Reduced lymphocyte proliferation in response to antigens.

Page 34: B cell immunodeficiency

Malignancy• Immunodeficiency caused by lymphoid tumours e.g. leukaemia, lymphoma,

plasma cell dyscrasias

• Hodgkin’s lymphoma: causes classic example of T-cell deficiency.

• Chronic lymphocytic leukaemia: causes classic example of B-cell deficiency.

Lymphocyte Depletion Hodgkin's Lymphoma

Page 35: B cell immunodeficiency

Human Immunodeficiency Virus (HIV)• Human retrovirus

• RNA genome.

• Targets host cell immune

system itself…

“abnormalities in

every arm of the

immune system”

Page 36: B cell immunodeficiency

Other causes for secondary immunodeficiency:

•  Irradiation - exposure to X-rays and gamma rays. Causes a decreased production of lymphocyte precursors in the bone marrow.

• Cytotoxic drugs such as many used in cancer chemotherapy. Causes a decreased production of lymphocyte precursors in the bone marrow.

• Corticosteroids – anti-inflammatory steroids. Damages lymphocytes.

• Aging. Adaptive immunity, especially cell-mediated immunity, tends to deminish

with aging. • Removal of the spleen. Decreased ability to remove microbes that enter the blood.

Page 37: B cell immunodeficiency

Category Examples

Endocrine Diabetes mellitus.

GI Hepatic insufficiency, hepatitis, intestinal lymphangiectasia, protein-losing enteropathy.

Hematologic Aplastic anemia, cancer, graft-vs-host disease, sickle cell disease.

Iatrogenic Certain drugs: chemotherapeutic drugs, immunosuppressants, corticosteroids Immunodeficiency Disorders: Some Drugs That Cause Immunosuppression radiation therapy; splenectomy.

infectious Cytomegalovirus, Epstein-Barr virus, HIV, measles virus, varicella-zoster virus.

Nutritional Alcoholism, undernutrition.

Physiologic Physiologic immunodeficiency in infants due to immaturity of immune system, pregnancy.

Renal Nephrotic syndrome, renal insufficiency, uremia.

Rheumatologic RA, SLE

Other Burns, chromosomal abnormalities (eg, Down syndrome), congenital asplenia, critical and chronic illness, histiocytosis, sarcoidosis.

Page 38: B cell immunodeficiency

Other clinical conditions• In studies performed to improve the accuracy of early diagnosis of retinoblastomas,

markedly reduced blood and lacrimal fluid IgG levels have been found in persons

with stage III-IV retinoblastoma.

• A relationship between febrile convulsion and IgG subclass deficiencies has also

been demonstrated. One study found that IgG subclass deficiencies may be

responsible for an increased incidence of febrile infections, which result in a higher

incidence of seizures in children who are predisposed to febrile seizures.

• IgG2, IgG4, and IgA subclass deficiencies may play a role in the pathogenesis of

allergic colitis in children.

Page 39: B cell immunodeficiency

• Infants with a definitive diagnosis of noninfective colitis displayed a high

prevalence of IgA, IgG2, and IgG4 deficiencies.

• Although some reports have suggested a strong relationship between IgG

subclass patterns and atopic disorders, other studies have not found this

association.

Page 40: B cell immunodeficiency

T cell deficiencies with variable degrees of B cell deficiency

Page 41: B cell immunodeficiency

Ataxia-telangiectasia

• Ataxia-telangiectasia is a deficiency of T cells associated with a lack of

coordination of movement (ataxis) and dilation of small blood vessels of the facial

area (telangiectasis).

• T-cells and their functions are reduced to various degrees.

• B cell numbers and IgM concentrations are normal to low. IgG is often reduced

and IgA is considerably reduced (in 70% of the cases).

• There is a high incidence of malignancy, particularly leukemias.

• The defects arise from a breakage in chromosome 14 at the site of TCR and Ig

heavy chain genes.

Page 42: B cell immunodeficiency

Wiskott-Aldrich syndrome (WAS)

• This syndrome is associated with normal T cell numbers with reduced functions,

which get progressively worse. IgM concentrations are reduced but IgG levels are

normal.

• Both IgA and IgE levels are elevated. Boys with this syndrome develop severe

eczema, petechia (due to platelet defect and thrombocytopenia).

• They respond poorly to polysaccharide antigens and are prone to pyogenic

infection. 

• Wiskott-Aldrich syndrome is an X-linked disorder due to defect in a cytoskeletal

glycoprotein, CD43.

Page 43: B cell immunodeficiency
Page 44: B cell immunodeficiency

Combined Immunodeficiency

Page 45: B cell immunodeficiency

Deficiencies in Cell Mediated Immunity

SCID

• SCID refers to severe combined immune deficiency which results in no, or low

numbers of, functional B and T cells.  By far the most profound effect on the

immune response is the lack of T cells. 

• Children with SCID are usually diagnosed in their first six months of life because

of severe bacterial, viral and fungal infections.  They must be kept isolated from

any potential for infection.  

• This is the classic “baby in the bubble” syndrome. 

Page 46: B cell immunodeficiency

• The prognosis is very poor unless their immune system can be reconstituted by

providing normal bone marrow stem cells through transplantation from an HLA-

matched donor.

• Since the development of B cells and T cells depends on a number of critical

steps, all going according to plan, a defect in any of these critical steps will result

in SCID. 

Page 47: B cell immunodeficiency

• A defect in the RAG genes which are required for gene rearrangement of both the

T cell receptor and antibody will result in an inability of either T cells or B cells

to reach maturity. 

• A common genetic defect leading to SCID is a problem in the gene coding for the

gamma chain of the IL-2 receptor.  This chain is also part of the receptors for IL-

4, IL-7, IL-9 and IL-15.  A defect in the gamma chain knocks out the activity of

all of these important cytokines and renders the immune response completely

ineffective.

• A defect in the JAK kinase signal transduction pathway activated by these

cytokines has a similar effect.

Page 48: B cell immunodeficiency
Page 49: B cell immunodeficiency
Page 50: B cell immunodeficiency

Thank you